Serotype and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from Taiwanese children: comparison of nasopharyngeal and clinical isolates

Diagnostic Microbiology and Infectious Disease

Volumn 56, Issue 4, 2006, Pages 421-426

  Lauderdale, Tsai Ling ^a,b   Wagener, Marilyn M ^c   Lin, Hui Min ^d   Huang, I Fei ^d,e   Lee, Wei Yang ^d,f   Hseih, Kai Sheng ^d,e   Lai, Jui Fen ^a   Chiou, Christine C ^d,e  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b JUNTENDO UNIVERSITY   (Japan)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f Kaohsiung Municipal United Hospital   (Taiwan)

Author keywords

Antimicrobial resistance; Pneumococcal vaccine; Serogroups; Serotypes; Streptococcus pneumoniae

Indexed keywords

CHLORAMPHENICOL; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; BLOOD GROUP TYPING; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NASOPHARYNX; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK; SEROTYPE; SPECIES INVASION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; TAIWAN; VACCINATION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CHLORAMPHENICOL; DAY CARE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS, URBAN; HUMANS; INFANT; MACROLIDES; NASOPHARYNGEAL DISEASES; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SENTINEL SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TAIWAN;

EID: 33845203437     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.06.006     Document Type: Article

References (27)

1. Bogaert D., De Groot R., and Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4 (2004) 144-154
2. Brueggemann A.B., Peto T.E., Crook D.W., Butler J.C., Kristinsson K.G., and Spratt B.G. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190 (2004) 1203-1211
3. Butler J.C., Shapiro E.D., and Carlone G.M. Pneumococcal vaccines: history, current status, and future directions. Am. J. Med. 107 (1999) 69S-76S
4. CDC. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb. Mortal. Wkly Rep. 54 (2005) 893-897
5. Chiou C.C., and McEllistrem M.C. Novel penicillin-, cephalosporin-, and macrolide-resistant clones of Streptococcus pneumoniae serotypes 23F and 19F in Taiwan which differ from international epidemic clones. J. Clin. Microbiol. 39 (2001) 1144-1147
6. Chiou C.C., Liu Y.C., Huang T.S., Hwang W.K., Wang J.H., Lin H.H., Yen M.Y., and Hsieh K.S. Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. J. Clin. Microbiol. 36 (1998) 1933-1937
7. Clinical and Laboratory Standards Institute (formerly NCCLS). Performance Standards for Antimicrobial Susceptibility Testing; 16th Informational Supplement. M100-S16. 26[3] (2006), Clinical and Laboratory Standards Institute, Wayne (Pa)
8. Dagan R., Melamed R., Muallem M., Piglansky L., and Yagupsky P. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J. Infect. Dis. 174 (1996) 1352-1355
9. Dagan R., Givon-Lavi N., Shkolnik L., Yagupsky P., and Fraser D. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines. J. Infect. Dis. 181 (2000) 1322-1329
10. Di Fabio J.L., Castaneda E., Agudelo C.I., De La H.F., Hortal M., Camou T., Echaniz-Aviles G., Noemi M., Barajas C., Heitmann I., Hormazabal J.C., Brandileone M.C., Dias V.V., Regueira M., Ruvinski R., Corso A., Lovgren M., Talbot J.A., and De Quadros C. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993 to 1999. PAHO Sireva-Vigia Study Group. Pan American Health Organization. Pediatr. Infect. Dis. J. 20 (2001) 959-967
11. Doit C., Loukil C., Geslin P., and Bingen E. Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children. J. Clin. Microbiol. 40 (2002) 2994-2998
12. Faden H., Duffy L., Wasielewski R., Wolf J., Krystofik D., and Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children. J. Infect. Dis. 175 (1997) 1440-1445
13. Ghaffar F., Barton T., Lozano J., Muniz L.S., Hicks P., Gan V., Ahmad N., and McCracken Jr. G.H. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin. Infect. Dis. 39 (2004) 930-938
14. Gray B.M., Converse III G.M., and Dillon Jr. H.C. Epidemiological studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 142 (1980) 923-933
15. Hausdorff W.P., Bryant J., Paradiso P.R., and Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 30 (2000) 100-121
16. Hausdorff W.P., Bryant J., Kloek C., Paradiso P.R., and Siber G.R. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin. Infect. Dis. 30 (2000) 122-140
17. Hausdorff W.P., Feikin D.R., and Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 5 (2005) 83-93
18. Johnson D.M., Stilwell M.G., Fritsche T.R., and Jones R.N. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn. Microbiol. Infect. Dis. (2006) [In Press]
19. Jones M.E., Blosser-Middleton R.S., Thornsberry C., Karlowsky J.A., and Sahm D.F. The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002. Diagn. Microbiol. Infect. Dis. 47 (2003) 579-586
20. Kellner J.D., McGeer A., Cetron M.S., Low D.E., Butler J.C., Matlow A., Talbot J., and Ford-Jones E.L. The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease. Pediatr. Infect. Dis. J. 17 (1998) 279-286
21. Klugman K.P., and Welsh K.J. Nasopharyngeal carriage of pneumococcal pediatric serotypes: a risk for acute and recurrent otitis media in children and for invasive disease in susceptible adults. J. Infect. Dis. 191 (2005) 1790-1792
22. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., and Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N. Engl. J. Med. 349 (2003) 1341-1348
23. Lauderdale T.L., Lee W.Y., Cheng M.F., Huang I.F., Lin Y.C., Hseih K.S., Huang I.W., and Chiou C.C. High carriage rate of high-level penicillin-resistant Streptococcus pneumoniae in a Taiwan kindergarten associated with a case of pneumococcal meningitis. BMC Infect. Dis. 5 (2005) 96
24. Lehmann D., Gratten M., and Montgomery J. Susceptibility of pneumococcal carriage isolates to penicillin provides a conservative estimate of susceptibility of invasive pneumococci. Pediatr. Infect. Dis. J. 16 (1997) 297-305
25. McEllistrem M.C., Adams J.M., Patel K., Mendelsohn A.B., Kaplan S.L., Bradley J.S., Schutze G.E., Kim K.S., Mason E.O., and Wald E.R. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis. 40 (2005) 1738-1744
26. Sniadack D.H., Schwartz B., Lipman H., Bogaerts J., Butler J.C., Dagan R., Echaniz-Aviles G., Lloyd-Evans G., Fenoll A., and Girgis N.I. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children-implications for vaccine strategies. Pediatr. Infect. Dis. J. 14 (1995) 503-510
27. Song J.H., Jung S.I., Ko K.S., Kim N.Y., Son J.S., Chang H.H., Ki H.K., Oh W.S., Suh J.Y., Peck K.R., Lee N.Y., Yang Y., Lu Q., Chongthaleong A., Chiu C.H., Lalitha M.K., Perera J., Yee T.T., Kumarasinghe G., Jamal F., Kamarulzaman A., Parasakthi N., Van P.H., Carlos C., So T., Ng T.K., and Shibl A. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob. Agents Chemother. 48 (2004) 2101-2107